Stroke News and Research

RSS

A stroke is a medical emergency. Strokes happen when blood flow to your brain stops. Within minutes, brain cells begin to die. There are two kinds of stroke. The more common kind, called ischemic stroke, is caused by a blood clot that blocks or plugs a blood vessel in the brain. The other kind, called hemorrhagic stroke, is caused by a blood vessel that breaks and bleeds into the brain. "Mini-strokes" or transient ischemic attacks (TIAs), occur when the blood supply to the brain is briefly interrupted.

Gene therapy may help correct molecular flaws that cause brain disease

Neuroscientists have forged an unlikely molecular union as part of their fight against diseases of the brain and nervous system.

9 Jan 2010

Nominations open for 2010 National Courage Award

Nominations are now being accepted for the 2010 National Courage Award. Since 1980, Minnesota-based Courage Center has presented the National Courage Award, which recognizes an individual's contributions to the health, welfare and rehabilitation of people with disabilities.

9 Jan 2010

Oxygen Biotherapeutics' common stock approved for listing on NASDAQ Capital Market

Oxygen Biotherapeutics, Inc. announced today that its common stock has been approved for listing on the NASDAQ Capital Market.

9 Jan 2010

MinuteClinic re-accredited and earns the Joint Commission's Gold Seal of Approval

MinuteClinic, the retail health care division of CVS Caremark (NYSE: CVS) and the pioneer and largest provider of retail-based medical clinics in the United States, has become the first retail clinic to be re-accredited and earn the Joint Commission's Gold Seal of Approval(TM) for consecutive evaluation periods by having demonstrated compliance with The Joint Commission's national standards for health care quality and safety.

9 Jan 2010

Chinese researchers become the world's fifth most prolific contributors to regenerative medicine

Chinese researchers have become the world's fifth most prolific contributors to peer-reviewed scientific literature on clock-reversing regenerative medicine even as a skeptical international research community condemns the practice of Chinese clinics administering unproven stem cell therapies to domestic and foreign patients.

8 Jan 2010

Amira Pharmaceuticals achieves another development milestone in its FLAP program

Amira Pharmaceuticals, Inc. announced today that it has achieved another development milestone in its FLAP program, which is partnered with GlaxoSmithKline. This milestone is related to the successful development of a solid dose formulation, which is critical for future development and commercialization activities.

8 Jan 2010

Combination of advanced techniques in robotics and neuroscience shows promise for stroke patients

Bioengineers have taken a small step toward improving physical recovery in stroke patients by showing that a key feature of how limb motion is encoded in the nervous system plays a crucial role in how new motor skills are learned.

8 Jan 2010

Positive results from phase 2 study evaluating the safety and efficacy of Qnexa announced

VIVUS, Inc. today announced positive results from a phase 2 study evaluating the safety and efficacy of Qnexa®, an investigational drug, for the treatment of obstructive sleep apnea (OSA). VIVUS recently completed phase 3 development of Qnexa for the treatment of obesity and submitted a New Drug Application (NDA) to the FDA for that indication.

7 Jan 2010

UV LED therapy can be used for treating focal epilepsy in humans

Researchers from the University of Minnesota Medical School discovered that light from an ultraviolet diode (UV LED) reduced "seizure-like" activity in a rat epilepsy model. During the study, UV light released gamma aminobutyric acid (GABA) from the "caged" compound carbonyl amino butanoic acid (BC204).

7 Jan 2010

New wireless monitoring device prevents and detects mobility problems among elderly

Falls are the main cause of injuries among elderly people, but until now doctors have had few ways of effectively monitoring and counteracting mobility problems among patients. Work by European researchers is set to change that.

7 Jan 2010

Dakim expands distribution of dementia-fighting Dakim BrainFitness System to Canada

Dakim, Inc. announced today that it is expanding distribution of its dementia-fighting Dakim® BrainFitness(TM) System to Canada through a partnership with Tock Tick, Inc. Dakim's touch screen-based system is the #1 cognitive stimulation product in U.S. senior living communities, providing an entertaining and easy-to-use brain workout that is specifically designed to help seniors maintain their brain health.

7 Jan 2010

Physicians perform first implantation of leadless cardiac monitoring device for detecting arrhythmias

BIOTRONIK SE & Co. KG, the pioneer of wireless remote monitoring technologies and leading manufacturer of implantable cardiac devices, today announced the first implantations of BIOTRONIK’s new leadless cardiac monitoring device performed by a team of physicians led by Professor Dr. Gerhard Hindricks, Director, Electrophysiology Department at the Leipzig Heart Center in Leipzig, Germany.

6 Jan 2010

Treatment with Effient more cost effective, show TRITON-TIMI 38 clinical trial results

Results from a health economic substudy of the TRITON-TIMI 38 clinical trial showed that among patients with acute coronary syndromes (ACS) managed with percutaneous coronary intervention (PCI), including stenting, treatment with Effient(®) (prasugrel) compared with branded clopidogrel (Plavix(®)) was more cost effective, and in most cases cost saving.

6 Jan 2010

'Make Today the Day' public awareness campaign to quit smoking launched

At a time when many smokers consider quitting for the New Year, today is a timely launch of a partnership that joins together mutual public health interests sought by the American Lung Association in California, Healthy San Francisco and the city's Public Health Office in a citywide public awareness campaign aimed to help smokers achieve that goal.

6 Jan 2010

Vitamin D deficiency may contribute to higher risk of death among African-Americans compared to whites

Vitamin D deficiency may contribute to a higher number of heart and stroke-related deaths among black Americans compared to whites, according to a University of Rochester Medical Center study.

6 Jan 2010

ARYx Therapeutics receives guidance in writing from FDA on tecarfarin

ARYx Therapeutics, Inc., a biopharmaceutical company, today announced that is has received guidance in writing from the U.S. Food and Drug Administration (FDA) confirming that the existing development pathway remains acceptable to seek regulatory approval of ARYx’s novel anticoagulant agent, tecarfarin (ATI-5923).

5 Jan 2010

Northwest Hospital & Medical Center collaborates with UW Medicine Health System to improve healthcare

Following final regulatory review, Northwest Hospital & Medical Center, a 281-bed full-service acute care hospital, has joined the UW Medicine Health System, effective January 1.

5 Jan 2010

Article provides issues and challenges encountered by hospitals in implementing cooling program for post arrest patients

The European Resuscitation Council (ERC) and Elsevier's journal Resuscitation chose a randomized controlled study demonstrating a trend toward faster cooling and better control with Medivance's Arctic Sun® Temperature Management System as its featured "Article of the Month."

5 Jan 2010

Citicoline supplements may reduce cravings and increase satiety

The obesity crisis in the United States has now grown to epidemic proportion. And as the list of consequential health conditions and diseases continues to expand as well, there are major movements toward helping Americans lose weight.

5 Jan 2010

Anti-inflammatory prescription drug reduces the risk of common skin cancer in humans

A widely-available anti-inflammatory prescription drug can reduce the risk of a common skin cancer in humans, according to a researcher at Stanford's School of Medicine.

5 Jan 2010

Stroke News and Research

Further Reading

Gene therapy may help correct molecular flaws that cause brain disease

Nominations open for 2010 National Courage Award

Oxygen Biotherapeutics' common stock approved for listing on NASDAQ Capital Market

MinuteClinic re-accredited and earns the Joint Commission's Gold Seal of Approval

Chinese researchers become the world's fifth most prolific contributors to regenerative medicine

Amira Pharmaceuticals achieves another development milestone in its FLAP program

Combination of advanced techniques in robotics and neuroscience shows promise for stroke patients

Positive results from phase 2 study evaluating the safety and efficacy of Qnexa announced

UV LED therapy can be used for treating focal epilepsy in humans

New wireless monitoring device prevents and detects mobility problems among elderly

Dakim expands distribution of dementia-fighting Dakim BrainFitness System to Canada

Physicians perform first implantation of leadless cardiac monitoring device for detecting arrhythmias

Treatment with Effient more cost effective, show TRITON-TIMI 38 clinical trial results

'Make Today the Day' public awareness campaign to quit smoking launched

Vitamin D deficiency may contribute to higher risk of death among African-Americans compared to whites

ARYx Therapeutics receives guidance in writing from FDA on tecarfarin

Northwest Hospital & Medical Center collaborates with UW Medicine Health System to improve healthcare

Article provides issues and challenges encountered by hospitals in implementing cooling program for post arrest patients

Citicoline supplements may reduce cravings and increase satiety

Anti-inflammatory prescription drug reduces the risk of common skin cancer in humans

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News